(CercleFinance.com) – The Paris Bourse soars by 1.4%, towards 6,575 points (the SBF-120 crossed again the 5,100): a score which reflects an apparent euphoria but such differences are mainly explained by the absence of counterpart seller (no one ‘stands in front of a funicular algo’ like the one identified from the pre-opening) on this day of Pentecost.
The volumes are completely anecdotal: less than 850MnsE in 6.5 hours of quotations.
Wall Street has just reopened up 0.6% for the Dow Jones, +1% for the Nasdaq after a significant correction on Friday (unlike Paris, which had fallen little but is recovering very strongly).
Note the closure of Frankfurt and Zurich: the rise of the day in Paris is all the more singular as no major publication is on the agenda (no publication this morning).
Moreover, buyers would forget all caution 48 hours before the meeting of the European Central Bank (ECB), which could begin to prepare investors for monetary tightening in the short term.
After the record inflation figures unveiled last week, the ECB appears under pressure to adopt a more restrictive monetary policy, with the possibility of a rate hike as of July.
It should be noted that after nine consecutive weeks of decline, bitcoin gained more than 6%, to 31,400 USD, while Ethereum climbed by +6.7%: would this also be a sign of a return of appetite? for the risk?
On the foreign exchange front, the euro gained 0.1% against the greenback and is now trading against $1.0710 after climbing up to around 1.0750.
North Sea Brent stabilized around 120 dollars a barrel.
As for values, Euroapi signs the strongest progression of the CAC this morning by arrogating more than 3.5% after the announcement of its first global employee shareholding plan, an operation which ‘aims to promote the feeling of belonging employees and involve them in the group’s long-term success and development.
Transgene shares are on the rise on the Paris Stock Exchange on Monday following the presentation of data deemed ‘promising’ at the annual ASCO oncology congress on the evaluation of its personalized therapeutic vaccine in ovarian cancer and head and neck cancer.
Finally, Carrefour indicates that its board of directors decided last Friday to reduce the share capital by canceling 12,506,325 repurchased shares, representing approximately 1.6% of the share capital.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
